These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24876761)

  • 1. Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion.
    Kida T; Morishita S; Kakurai K; Suzuki H; Oku H; Ikeda T
    Clin Ophthalmol; 2014; 8():955-8. PubMed ID: 24876761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consecutive central and branch retinal vein occlusions in the same eye of a young healthy COVID-19 patient: A unique case report.
    Altıntaş AG; Ekici E
    Am J Ophthalmol Case Rep; 2022 Sep; 27():101669. PubMed ID: 35938144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
    Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
    JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.
    Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; King J; Antoszyk AN; Peters MA; Tolentino M;
    JAMA Ophthalmol; 2017 Jun; 135(6):639-649. PubMed ID: 28492860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
    Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
    Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion-related macular edema.
    Kida T; Flammer J; Konieczka K; Ikeda T
    Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):1853-1858. PubMed ID: 33447857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion.
    Jung SH; Kim KA; Sohn SW; Yang SJ
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2290-6. PubMed ID: 24398091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
    Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QUALITATIVE AND QUANTITATIVE FOLLOW-UP USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VEIN OCCLUSION TREATED WITH ANTI-VEGF: Optical Coherence Tomography Angiography Follow-up of Retinal Vein Occlusion.
    Sellam A; Glacet-Bernard A; Coscas F; Miere A; Coscas G; Souied EH
    Retina; 2017 Jun; 37(6):1176-1184. PubMed ID: 27685676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal oximetry during treatment of retinal vein occlusion by ranibizumab in patients with high blood pressure and dyslipidemia.
    Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
    J Fr Ophtalmol; 2016 Dec; 39(10):816-821. PubMed ID: 27865689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion.
    Gutiérrez JC; Barquet LA; Caminal JM; Mitjana ; Almolda SP; Domènech NP; Goita OP; Caso MR; Ginebreda JA
    Clin Ophthalmol; 2008 Dec; 2(4):787-91. PubMed ID: 19668432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion.
    Farese E; Cennamo G; Velotti N; Traversi C; Rinaldi M; De Crecchio G
    Eur J Ophthalmol; 2014; 24(5):761-70. PubMed ID: 24585424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab.
    Yoo SG; Kim JH; Lee TG; Kim CG; Kim JW
    Indian J Ophthalmol; 2015 Jan; 63(1):25-9. PubMed ID: 25686058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
    Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
    Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Follow-Up Changes of Central Choroidal Thickness Thinning after Repeated Anti-VEGF Therapy Injections in Patients with Central Retinal Vein Occlusion-Related Macular Edema with Systemic Hypertension.
    Kida T; Osuka S; Fukumoto M; Sato T; Harino S; Oku H; Ikeda T
    Ophthalmologica; 2020; 243(2):102-109. PubMed ID: 31851998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab in retinal vein occlusion-results of a prospective case series.
    Stahl A; Agostini H; Hansen LL; Feltgen N
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1429-36. PubMed ID: 17356824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.